{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:37:34Z","timestamp":1784752654729,"version":"3.55.0"},"reference-count":30,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T00:00:00Z","timestamp":1343347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1002\/ajh.23286","type":"journal-article","created":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T11:38:05Z","timestamp":1339155485000},"source":"Crossref","is-referenced-by-count":1,"title":["Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost\u2010effective and safer treatment of advanced follicular lymphoma"],"prefix":"10.1002","volume":"87","author":[{"given":"F.","family":"McClanahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hielscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hensel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Schmidt\u2010Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"K\u00e4bisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Salwender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"D\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Staiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Neben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hillengass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Witzens\u2010Harig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,7,27]]},"reference":[{"key":"e_1_2_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.6.2188"},{"key":"e_1_2_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2825"},{"key":"e_1_2_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770000163"},{"key":"e_1_2_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.1.101"},{"key":"e_1_2_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.04.020"},{"key":"e_1_2_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-153189"},{"key":"e_1_2_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0016"},{"key":"e_1_2_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.5376"},{"key":"e_1_2_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-04-1323"},{"key":"e_1_2_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.1561"},{"key":"e_1_2_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62175-7"},{"key":"e_1_2_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-016725"},{"key":"e_1_2_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.4786"},{"key":"e_1_2_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.5827"},{"key":"e_1_2_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008395214584"},{"key":"e_1_2_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01965.x"},{"key":"e_1_2_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07101.x"},{"key":"e_1_2_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2490"},{"key":"e_1_2_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.856"},{"key":"e_1_2_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.0852"},{"key":"e_1_2_1_3_1_22_2","doi-asserted-by":"crossref","unstructured":"Hensel M Scheuer L Salwender H et al. How much rituximab do we need: A multicenter randomized trial comparing 1 3 or 6 infusions of rituximab added to 6 cycles of CHOP chemotherapy in untreated patients with advanced follicular non\u2010Hodgkins lymphoma (HD2000\u2010Trial). In Blood (ASH Annual Meeting Abstracts) Edition2004;Abstract 4584.","DOI":"10.1182\/blood.V104.11.4584.4584"},{"key":"e_1_2_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0806-7"},{"key":"e_1_2_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-186999"},{"key":"e_1_2_1_3_1_25_2","doi-asserted-by":"crossref","unstructured":"RummelMJ NiederleN MaschmeyerG et al. Bendamustine plus rituximab is superior in respect of progression free survival and CR rate when compared to CHOP plus rituximab as first\u2010line treatment of patients with advanced follicular indolent and mantle cell lymphomas: Final results of a randomized phase III study of the StiL (Study Group Indolent Lymphomas Germany). In: ASH Annual Meeting Abstracts Edition2009;405.","DOI":"10.1182\/blood.V114.22.405.405"},{"key":"e_1_2_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.4618"},{"key":"e_1_2_1_3_1_27_2","first-page":"1905","article-title":"NOAUTHORSLISTED. ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group","volume":"18","year":"1999","journal-title":"Stat Med"},{"key":"e_1_2_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0550-4"},{"key":"e_1_2_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.8.2955.2955_2955_2960"},{"key":"e_1_2_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.1.268"},{"key":"e_1_2_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830290307"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.23286","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.23286","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.23286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T06:20:11Z","timestamp":1694413211000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.23286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,27]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1002\/ajh.23286"],"URL":"https:\/\/doi.org\/10.1002\/ajh.23286","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,27]]}}}